Jane E. Remillard

Massachusetts

Nelson Mullins Riley & Scarborough LLP
One Financial Center
Suite 3500
Boston, MA 02111

Tel: 617.217.4628

Email: jane.remillard@nelsonmullins.com
Web: www.nelsonmullins.com

Professional Biography

Jane Remillard is a Partner in the Boston office of Nelson Mullins, where she co-chairs the firm’s Intellectual Property Management Group.

Jane brings more than 30 years of experience in worldwide patent counseling and strategic planning for the biotechnology and pharmaceutical industries. Her work centers on developing and executing effective intellectual property strategies, building and managing strong patent portfolios, and supporting the commercialization of innovative products, particularly antibody-based therapeutics, across all stages of development.

Her practice encompasses patent prosecution, freedom-to-operate analyses, opinion work, licensing and other agreements, due diligence, and a wide range of post-grant and contested proceedings, including interferences, re-examinations, reissues, inter partes reviews, and oppositions. She works with clients ranging from emerging biotechnology companies to established pharmaceutical organizations, helping them protect key technologies and navigate complex IP landscapes.

Jane has significant experience conducting IP due diligence in connection with collaborations, acquisitions, licensing arrangements, and financing transactions in the life sciences sector. She also represents companies in private and public offerings in the United States and internationally, and advises investors on evaluating the strength and scope of intellectual property assets held by prospective investment targets.

  • Providing strategic patent counseling including patent preparation, prosecution, freedom to operate evaluations, re-examinations, re-issues, inter partes reviews, and oppositions in a broad variety of technologies and discovery platforms, including immunotherapeutics, recombinant proteins, peptides, biomarkers, diagnostics, vaccines, stem cells, gene therapy and cell based assays.
  • Developing and implementing effective IP strategies, including building strong patent portfolios to protect products from discovery through next generation.
  • Conducting due diligence evaluations for collaborations, acquisitions, licensing, and financing transactions.
  • Representing clients in private and public offerings, both in the United States and abroad.
  • Advising clients in assessing the strength of intellectual property assets held by prospective candidates for investment.
  • Preparing, prosecuting, and opining on patents in the fields of immunology, oncology, virology, neurology, and cell biology for clients ranging from start-up biotechnology companies to established pharmaceutical corporations.

  • The Best Lawyers in America®, Patent Law (2015–2026)
  • Connecticut Law Tribune – New England Legal Awards, IP Attorney of the Year Finalist (2024)
  • Chambers and Partners USA: Intellectual Property – Massachusetts (2014–2025)
  • Massachusetts Go To Intellectual Property Attorneys, Massachusetts Lawyers Weekly (2021)
  • Patent Strategy Attorney of the Year, LMG Life Sciences (2021)
  • Managing Intellectual Property magazine, Patent Star (2020–2023), Top 250 Women in IP (2022–2023)
  • Profiles in Diversity Journal, Women Worth Watching in STEM® (2020)
  • LMG Life Sciences, Star in Intellectual Property for Patent Strategy & Management (2019–2023); shortlisted for Patent Strategy Attorney of the Year Award (2021 and 2022); Winner of Patent Strategy Attorney of the Year Award (2021)
  • The Best Lawyers in America®, Lawyer of the Year, Boston, MA, Patent Law (2022)
  • Massachusetts Super Lawyers, Intellectual Property
    • Super Lawyer (2009–2025)
    • Rising Star (2006–2007)
    • Top Women Attorneys in Massachusetts (2014)
    • Top 50 Women Massachusetts (2011–2013)
    • Top 100 Massachusetts (2011)
  • Honoree of the Annual Boston University Law Women in Law Conference (2009)

Nelson Mullins’ Patent Counseling and Procurement practice delivers comprehensive patent strategy, preparation, and portfolio services to a broad base of domestic and international clients. The team helps organizations navigate rapidly emerging technologies, identify innovations, and align patent strategy with business objectives, offering counsel at every stage—from assessing patentability and managing development portfolios to obtaining protection for new inventions and responding to evolving laws and competitive landscapes. Attorneys in the practice hold registrations before the U.S. Patent and Trademark Office and possess technical backgrounds across disciplines such as chemistry, engineering, biotechnology, and physics, combining legal acumen with deep technical insight.

The group’s practitioners draw on real-world experience—including backgrounds as former in-house counsel, patent examiners, federal clerks, and academic leaders—to provide counsel tailored to the unique needs of each client. Clients range from biotechnology start-ups and research institutions to global corporations across industries such as industrial chemicals, medical treatments, software, and pharmaceuticals. With an understanding of both U.S. and international patent systems and an expansive global network, the practice supports clients in building and maintaining strong patent portfolios and in implementing strategies that offer competitive advantage and commercial value.

Nelson Mullins Riley & Scarborough LLP is a leading full-service U.S. law firm with deep roots dating back to its founding in 1897. The firm provides strategic legal counsel to businesses, institutions, and individuals across a broad range of industries and practice areas, aligning legal strategies with clients’ commercial objectives in everything from complex litigation and corporate transactions to regulatory matters and government relations.

With more than 1,000 attorneys, policy advisors, and legal professionals, Nelson Mullins serves clients in more than 100 practice areas and is recognized nationally for both its depth of expertise and practical, business-focused approach.

Nelson Mullins has grown into a national platform with over 30 offices spanning 17 U.S. states and Washington, D.C., enabling it to provide seamless cross-office collaboration and local insight for clients of all sizes. Through its multidisciplinary teams and commitment to service, the firm supports clients from emerging companies to Fortune 500 enterprises across the country.

“Jane Remillard is a highly regarded life sciences IP attorney with decades of experience in patent strategy. Clients value her ability to build and manage sophisticated biotech and pharmaceutical patent portfolios, while peers recognize her depth in complex post-grant proceedings and strategic IP management.”
The Patent Lawyers, 2026